Intercept Pharmaceuticals completed its follow on public offering (FPO) with attorney from the Life Sciences Practice representing the company.
Healthcare Health/Fitness
Net Medical Xpress Acquires MedTel Solutions
Net Medical Xpress acquired MedTel Solutions, a telemedicine staffing company. Net Medical Xpress Solutions, Inc. announced today that it acquired MedTel Solutions, a Huntsville, AL-based telemedicine staffing company.
Zook heads First Manhattan if Vivus clash triumphs
Anthony Zook said that he will accept the job as CEO of First Manhattan if it wins the conflict against Vivus Inc.
Serco gains U.S. health contract worth US$1.25 billion
Serco won a contract with US Department of Health worth US$1.25 billion which resulted to 6.2% soar of its shares.
Mnemosyne Gets Financing for Schizophrenia and Rett Syndrome Treatments
Mnemosyne gets $6.9 million financing for schizophrenia and Rett Syndrome treatments. (Photo : Reuters)Mnemosyne’s efforts are focuse at drug discovery for treatment of schizophrenia and Rett Syndrome.
Latest News
Pharmaceutical companies Novartis and Pfizer showing interest in Onyx (Photo : Reuters)Onyx Pharmaceuticals Inc Logo Pharmaceutical companies Novartis and Pfizer join the bandwagon as potential bidders for Onyx Pharmaceuticals Inc, sources close to the situation conferred on Monday.
The following bids, mergers, acquisitions and disposals were reported on Monday The following bids, mergers, acquisitions and disposals were reported on Monday: - Chinese state oil firm CNPC will buy a stake in Kazakhstan's giant Kashagan oil project, through back-to-back deals with Kazmunaigaz through which ConocoPhillips will exit, the Kazakh state oil firm said on Monday.
McKesson Corp and Cardinal Health Inc are in talks with Celesio for its stakes, two sources said. (Photo : )The photo shows Celesio's, a German drugs company, official logo.
UrgentRx named Michael Valentino as its new member of the board. (Photo : Reuters)This is the logo of UrgentRx. Flavored medications developer UrgentRx said on Monday that it welcomed Michael Valentino to its board of directors.
Onyx Pharmaceuticals Inc stated that it has rejected the unsolicited bid from Amgen Inc priced at US$120 per share piece.
Amgen announced an offered acquisition for biotech Onyx Pharmaceuticals at US$120 per share piece.
Boston Scientific expands with a new prospect, Bard's electrophysiology unit, worth US$275 million.
Fresenius sold its transplantation medicine and anti-cancer cell drug to Neopharm. (Photo : Reuters)The image is the front foyer of German healthcare giant Fresenius SE.
ReproCell share values, after an initial hiccup, rose exponentially from 3,200 yen per share to 18,300 per share.
